- Home
- LANV vs TOI Comparison
LANV vs TOI Comparison
Compare LANV & TOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LANV
- TOI
- Stock Information
- Founded
- LANV 2015
- TOI 2007
- Country
- LANV China
- TOI United States
- Employees
- LANV N/A
- TOI N/A
- Industry
- LANV Blank Checks
- TOI Medical/Nursing Services
- Sector
- LANV Finance
- TOI Health Care
- Exchange
- LANV Nasdaq
- TOI Nasdaq
- Market Cap
- LANV 258.1M
- TOI 266.8M
- IPO Year
- LANV N/A
- TOI N/A
- Fundamental
- Price
- LANV $2.07
- TOI $2.47
- Analyst Decision
- LANV
- TOI
- Analyst Count
- LANV 0
- TOI 0
- Target Price
- LANV N/A
- TOI N/A
- AVG Volume (30 Days)
- LANV 36.4K
- TOI 2.0M
- Earning Date
- LANV 04-30-2025
- TOI 08-12-2025
- Dividend Yield
- LANV N/A
- TOI N/A
- EPS Growth
- LANV N/A
- TOI N/A
- EPS
- LANV N/A
- TOI N/A
- Revenue
- LANV $340,211,202.00
- TOI $403,152,000.00
- Revenue This Year
- LANV $11.74
- TOI $23.95
- Revenue Next Year
- LANV $11.11
- TOI N/A
- P/E Ratio
- LANV N/A
- TOI N/A
- Revenue Growth
- LANV N/A
- TOI 17.64
- 52 Week Low
- LANV $0.91
- TOI $0.13
- 52 Week High
- LANV $2.69
- TOI $3.50
- Technical
- Relative Strength Index (RSI)
- LANV 44.29
- TOI 42.15
- Support Level
- LANV $2.02
- TOI $2.49
- Resistance Level
- LANV $2.18
- TOI $2.87
- Average True Range (ATR)
- LANV 0.12
- TOI 0.28
- MACD
- LANV -0.02
- TOI -0.09
- Stochastic Oscillator
- LANV 26.13
- TOI 3.32
About LANV Lanvin Group Holdings Limited
Lanvin Group Holdings Ltd engages in offering products ranging from apparel to leather goods, footwear, and accessories. The firm is operating mainly 5 portfolio brands, namely Lanvin, Wolford, Sergio Rossi, St. John, and Caruso. It derives the majority of its revenue from the Wolford segment.
About TOI The Oncology Institute Inc.
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services. Majority of revenue is from patients services.